Live
- Share of top 50 stocks to total market cap at all-time low: Report
- Nortje ruled out of SA’s remaining white-ball matches against Pakistan
- Mamata doesn't want INDIA bloc to succeed, claims BJP's Rahul Sinha
- Air India Express cancels flights at Chennai airport due to deluge
- Kejriwal promises Rs 2,100 for Delhi women if AAP wins polls, BJP takes ‘lollipop’ jibe
- JPC Chairman supports Assam govt's 'No NRC, No Aadhaar,' rule
- Stoinis vows to revive Melbourne Stars’ glory with fresh leadership
- DDA easing freehold conversion of shops: MoS Sahu
- CP Sudheer Babu Updates on Manchu Family Cases
- Keerthy Suresh Marries Long-time Friend Antony Thattil in Goa
Pharma stocks are top sectoral gainers in trade
Pharma and healthcare stocks are top gainers on Wednesday with the index up 2.7 per cent.
New Delhi: Pharma and healthcare stocks are top gainers on Wednesday with the index up 2.7 per cent.
BSE Healthcare index is the top gainer among all sectoral indices on Wednesday.
Sun Pharma is the top Sensex gainer with gains of more than 3 per cent. Dr Reddy’s is up more than 4 per cent. Max Healthcare is up 6 per cent.
Gland Pharma is up 6 per cent, Wockhardt is up 4 per cent, Alembic Pharma is up 6 per cent.
The Fed decision tonight and the interim Budget tomorrow will weigh on markets in the near-term, says V K Vijayakumar, Chief Investment Strategist, Geojit Financial Services.
Global markets will be keenly watching the Fed comment on the timeline and quantum of rate cuts. The first rate cut is likely to come in June 2024. The decline in the 10-year yield to 4.02% is positive since it will restrain FPI outflows, he said.
The domestic market will be focused on the interim Budget particularly on any proposals regarding taxation of investments relating to the capital market. The fiscal deficit and its glide path also is important since growth with stability is hugely important from the market perspective, he said.
Stock specific movements are likely in response to sectoral allocations in the Budget, he added.
